International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7799136
Original Article
A Study On HbA1c And Serum Uric Acid Level In Diagnosed Patients Of Diabetes Mellitus Type 2
 ,
 ,
 ,
Published
April 2, 2023
Abstract
The association between serum uric acid levels and glycemic control in diabetic patients was not fully clarified. This study aimed to investigate the correlation between uric acid levels and glycemic control in patients with type II diabetes mellitus. A total of 140 patients were recruited and their uric acid levels and glycated hemoglobin (HbA1c) levels were measured. The results showed a significant positive correlation between uric acid levels and HbA1c levels, indicating that higher levels of uric acid were associated with poorer glycemic control in patients with type II diabetes. Moreover, patients with higher uric acid levels were found to have a higher risk of developing diabetic complications. These findings suggest that monitoring uric acid levels may be a useful marker for assessing glycemic control and predicting diabetic complications in type II diabetic patients.
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
1957 Views
222 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved